102 related articles for article (PubMed ID: 10497879)
1. Binding and signalling properties of a growth hormone enhancing monoclonal antibody.
Beattie J; Bramani S; Secchi C; Mockridge J
Mol Cell Biochem; 1999 Aug; 198(1-2):61-7. PubMed ID: 10497879
[TBL] [Abstract][Full Text] [Related]
2. Effects of complexation with in vivo enhancing monoclonal antibodies on activity of growth hormone in two responsive cell culture systems.
Beattie J; Borromeo V; Bramani S; Secchi C; Baumbach WR; Mockridge J
J Mol Endocrinol; 1999 Dec; 23(3):307-13. PubMed ID: 10601976
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of recombinant bovine GH (rbGH) activity in vitro by in vivo enhancing monoclonal antibodies.
Beattie J; Phillips K; Borromeo V
Mol Cell Biochem; 2001 Apr; 220(1-2):103-8. PubMed ID: 11451369
[TBL] [Abstract][Full Text] [Related]
4. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
[TBL] [Abstract][Full Text] [Related]
5. Location of an epitope defined by an enhancing monoclonal antibody to growth hormone: some structural details and biological implications.
Beattie J; Holder AT
Mol Endocrinol; 1994 Aug; 8(8):1103-10. PubMed ID: 7527900
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
Eriksson H; Ridderstråle M; Tornqvist H
Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
[TBL] [Abstract][Full Text] [Related]
8. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular WEIGHT protein immunologically related to JAK2.
Jiang J; Liang L; Kim SO; Zhang Y; Mandler R; Frank SJ
Biochem Biophys Res Commun; 1998 Dec; 253(3):774-9. PubMed ID: 9918803
[TBL] [Abstract][Full Text] [Related]
10. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to bovine growth hormone potentiate hormonal activity in vivo by enhancing growth hormone binding to hepatic somatogenic receptors.
Massart S; Maiter D; Portetelle D; Adam E; Renaville R; Ketelslegers JM
J Endocrinol; 1993 Dec; 139(3):383-93. PubMed ID: 8133207
[TBL] [Abstract][Full Text] [Related]
12. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.
Stred SE; Stubbart JR; Argetsinger LS; Smith WC; Shafer JA; Talamantes F; Carter-Su C
Endocrinology; 1992 Mar; 130(3):1626-36. PubMed ID: 1537311
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types.
Stred SE; Stubbart JR; Argetsinger LS; Shafer JA; Carter-Su C
Endocrinology; 1990 Nov; 127(5):2506-16. PubMed ID: 2171917
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone antagonists on 3T3-F442A preadipocyte differentiation.
Xu BC; Chen WY; Gu T; Ridgway D; Wiehl P; Okada S; Kopchick JJ
J Endocrinol; 1995 Jul; 146(1):131-9. PubMed ID: 7561609
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
King AP; Carter-Su C
Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209
[TBL] [Abstract][Full Text] [Related]
16. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ
Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746
[TBL] [Abstract][Full Text] [Related]
17. Binding and signalling properties of a GH-enhancing monoclonal antibody.
Beattie J; Mockridge J; Bramani S; Davies H; Marshall N; Buckle PE
Biochem Soc Trans; 1998 Feb; 26(1):S56. PubMed ID: 10909814
[No Abstract] [Full Text] [Related]
18. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
19. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]